The group testing the efficacy of HSP inhibition combined with other drugs (i.e., fludarabine, 17-DMAG) reported an enhanced apoptosis induction in CLL, supporting the use of the inhibition of HSP70 alone or in combination to treat CLL. This evidence concerns the gene HSPA4 and B-cell chronic lymphocytic leukemia.